PolyPeptide Group calls extraordinary general meeting

PolyPeptide will hold an extraordinary general meeting in Baar, Switzerland on Oct. 26, 2026. Shareholders will vote on removing transfer restrictions and voting limitations from the company’s articles of association. The meeting will also decide on electing Samsung Biologics’ nominees to PolyPeptide’s board of directors. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPeptide Group AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2414494_en) on October 13, 2026, and is solely responsible for the information contained therein. (C)